Next Article in Journal
Efficient Double Suzuki Cross-Coupling Reactions of 2,5-Dibromo-3-hexylthiophene: Anti-Tumor, Haemolytic, Anti-Thrombolytic and Biofilm Inhibition Studies
Next Article in Special Issue
Beneficial Effects of Trillium govanianum Rhizomes in Pain and Inflammation
Previous Article in Journal
Green Tea Leaves Extract: Microencapsulation, Physicochemical and Storage Stability Study
Previous Article in Special Issue
Intra-Population Variation of Secondary Metabolites in Cistus ladanifer L.
Article Menu
Issue 8 (August) cover image

Export Article

Open AccessReview
Molecules 2016, 21(8), 974; doi:10.3390/molecules21080974

Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks

1
Laboratory of Cell Biology and Unit for Multidisciplinary Research in Biomedicine (UMIB), Department of Microscopy, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal
2
Health Sciences Research Centre (CICS–UBI), University of Beira Interior, 6201-506 Covilhã, Portugal
3
Institute of Health Research an Innovation, University of Porto, 4200-135 Porto, Portugal
*
Author to whom correspondence should be addressed.
Academic Editors: Marcello Iriti and Derek J. McPhee
Received: 22 April 2016 / Revised: 2 July 2016 / Accepted: 19 July 2016 / Published: 27 July 2016
View Full-Text   |   Download PDF [1033 KB, uploaded 27 July 2016]   |  

Abstract

Methylxanthines are a group of phytochemicals derived from the purine base xanthine and obtained from plant secondary metabolism. They are unobtrusively included in daily diet in common products as coffee, tea, energetic drinks, or chocolate. Caffeine is by far the most studied methylxanthine either in animal or epidemiologic studies. Theophylline and theobromine are other relevant methylxanthines also commonly available in the aforementioned sources. There are many disseminated myths about methylxanthines but there is increased scientific knowledge to discuss all the controversy and promise shown by these intriguing phytochemicals. In fact, many beneficial physiologic outcomes have been suggested for methylxanthines in areas as important and diverse as neurodegenerative and respiratory diseases, diabetes or cancer. However, there have always been toxicity concerns with methylxanthine (over)consumption and pharmacologic applications. Herein, we explore the structure-bioactivity relationships to bring light those enumerated effects. The potential shown by methylxanthines in such a wide range of conditions should substantiate many other scientific endeavors that may highlight their adequacy as adjuvant therapy agents and may contribute to the advent of functional foods. Newly designed targeted molecules based on methylxanthine structure may originate more specific and effective outcomes. View Full-Text
Keywords: caffeine; cancer; diabetes; methylxanthine; neurodegenerative diseases; structure-activity relationship; theobromine; theophylline caffeine; cancer; diabetes; methylxanthine; neurodegenerative diseases; structure-activity relationship; theobromine; theophylline
Figures

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Monteiro, J.P.; Alves, M.G.; Oliveira, P.F.; Silva, B.M. Structure-Bioactivity Relationships of Methylxanthines: Trying to Make Sense of All the Promises and the Drawbacks. Molecules 2016, 21, 974.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top